PLN 142.2
(-2.47%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -6.89 PLN | -105.82% |
2022 | 118.34 PLN | 6361.38% |
2021 | -1.89 PLN | 35.05% |
2020 | -2.91 PLN | -6.59% |
2019 | -2.73 PLN | -54.24% |
2018 | -1.77 PLN | 2.21% |
2017 | -1.81 PLN | -16.77% |
2016 | -1.55 PLN | -451.6% |
2015 | -0.28 PLN | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -2.51 PLN | 14.04% |
2024 Q2 | -2.42 PLN | 3.59% |
2023 Q3 | -1.94 PLN | -110.87% |
2023 Q2 | -0.92 PLN | 17.12% |
2023 Q1 | -1.11 PLN | 9.02% |
2023 FY | - PLN | -105.82% |
2023 Q4 | -2.92 PLN | -50.52% |
2022 Q1 | -1.32 PLN | 63.33% |
2022 Q3 | 125.39 PLN | 8572.3% |
2022 Q4 | -1.22 PLN | -100.97% |
2022 Q2 | -1.48 PLN | -12.12% |
2022 FY | - PLN | 6361.38% |
2021 Q1 | -1.19 PLN | -9.17% |
2021 FY | - PLN | 35.05% |
2021 Q2 | -0.20 PLN | 83.19% |
2021 Q3 | -1.54 PLN | -670.0% |
2021 Q4 | -3.60 PLN | -133.77% |
2020 Q3 | -0.65 PLN | -41.3% |
2020 FY | - PLN | -6.59% |
2020 Q1 | -0.68 PLN | 31.31% |
2020 Q2 | -0.46 PLN | 32.35% |
2020 Q4 | -1.09 PLN | -67.69% |
2019 Q4 | -0.99 PLN | -50.0% |
2019 Q3 | -0.66 PLN | -34.69% |
2019 Q2 | -0.49 PLN | 14.04% |
2019 Q1 | -0.57 PLN | -39.02% |
2019 FY | - PLN | -54.24% |
2018 Q2 | -0.30 PLN | 42.31% |
2018 FY | - PLN | 2.21% |
2018 Q4 | -0.41 PLN | 16.33% |
2018 Q3 | -0.49 PLN | -63.33% |
2018 Q1 | -0.52 PLN | -13.04% |
2017 Q2 | -0.37 PLN | 11.9% |
2017 Q3 | -0.56 PLN | -51.35% |
2017 Q4 | -0.46 PLN | 17.86% |
2017 FY | - PLN | -16.77% |
2017 Q1 | -0.42 PLN | -223.08% |
2016 Q2 | -0.21 PLN | 41.67% |
2016 Q3 | -0.48 PLN | -128.57% |
2016 Q4 | -0.13 PLN | 72.92% |
2016 FY | - PLN | -451.6% |
2016 Q1 | -0.36 PLN | 0.0% |
2015 FY | - PLN | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
BioMaxima S.A. | 0.14 PLN | 5021.429% |
Selvita S.A. | 3.81 PLN | 280.84% |
Voxel S.A. | 7.70 PLN | 189.481% |